Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues
Saved in:
Main Author: | Azar Baradaran (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2012-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation of monocyte/high density lipoprotein cholesterol ratio with progression and prognosis of type 2 diabetic nephropathy
by: Nan Jiang, et al.
Published: (2024) -
Antiphospholipid syndrome-associated nephropathy; a nephropathy needs classification
by: Baradaran Azar
Published: (2012) -
Hypoglycemia in Patients with Type-2 Diabetes Mellitus Nephropathy
by: Faheem Ur Rahman, et al.
Published: (2023) -
Fractalkine in type 2 Egyptian diabetics with and without nephropathy
by: Ebtissam Zakaria, et al.
Published: (2013) -
Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes
by: Damien Denimal
Published: (2023)